Surrozen, Inc. Common (SRZN) is a publicly traded Healthcare sector company. As of July 25, 2026, SRZN trades at $19.69 with a market cap of $245.68M and a P/E ratio of -0.48. SRZN moved -6.95% today. Year to date, SRZN is -8.45%; over the trailing twelve months it is +123.57%. Its 52-week range spans $5.90 to $35.00. Analyst consensus is strong buy with an average price target of $43.33. Rallies surfaces SRZN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for SRZN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $19.69 |
| Market Cap | $245.68M |
| P/E Ratio | -0.48 |
| EPS | $-41.34 |
| Dividend Yield | 0.00% |
| 52-Week High | $35.00 |
| 52-Week Low | $5.90 |
| Volume | 173.04K |
| Avg Volume | 0 |
| Revenue (TTM) | $7.49M |
| Net Income | $-342.56M |
| Gross Margin | 0.00% |
4 analysts cover SRZN: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $43.33.